Comparison of a Novel Formulation of Abiraterone Acetate vs. the Originator Formulation in Healthy Male Subjects: Two Randomized, Open-Label, Crossover Studies

被引：0
|
作者：
Ronald Goldwater
Azra Hussaini
Bill Bosch
Paul Nemeth
机构：
[1] PAREXEL Early Phase Clinical Unit,
[2] Churchill Pharmaceuticals LLC,undefined
来源：
Clinical Pharmacokinetics | 2017年 / 56卷
关键词：
Meloxicam; Abiraterone; Healthy Male Subject; Abiraterone Acetate; Dose Proportionality;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：803 / 813
页数：10
相关论文
共 50 条
  • [31] A Randomized, Open-Label, Crossover Study Evaluating the Effect of Food on the Relative Bioavailability of Linagliptin in Healthy Subjects
    Graefe-Mody, Ulrike
    Giessmann, Thomas
    Ring, Arne
    Iovino, Mario
    Woerle, Hans-Juergen
    CLINICAL THERAPEUTICS, 2011, 33 (08) : 1096 - 1103
  • [32] Effect of Food on the Pharmacokinetics of Clozapine Orally Disintegrating Tablet 12.5 mgA Randomized,Open-Label,Crossover Study in Healthy Male Subjects
    Anthony R. DiSanto
    Gil Golden
    Clinical Drug Investigation, 2009, 29 : 539 - 549
  • [33] Effect of Food on the Pharmacokinetics of Clozapine Orally Disintegrating Tablet 12.5 mg A Randomized, Open-Label, Crossover Study in Healthy Male Subjects
    DiSanto, Anthony R.
    Golden, Gil
    CLINICAL DRUG INVESTIGATION, 2009, 29 (08) : 539 - 549
  • [34] Orally Formulated Artemisinin in Healthy Fasting Vietnamese Male Subjects: A Randomized, Four-Sequence, Open-Label, Pharmacokinetic Crossover Study
    Tran Tinh Hien
    Hanpithakpong, Warunee
    Nguyen Thanh Truong
    Nguyen Thi Dung
    Pham Van Toi
    Farrar, Jeremy
    Lindegardh, Niklas
    Tarning, Joel
    Ashton, Michael
    CLINICAL THERAPEUTICS, 2011, 33 (05) : 644 - 654
  • [35] Effects of Food and Antacids on the Pharmacokinetics of Eltrombopag in Healthy Adult Subjects: Two Single-Dose, Open-Label, Randomized-Sequence, Crossover Studies
    Williams, Daphne D.
    Peng, Bin
    Bailey, Christine K.
    Wire, Mary B.
    Deng, Yanli
    Park, Jung Wook
    Collins, David A.
    Kapsi, Shiva G.
    Jenkins, Julian M.
    CLINICAL THERAPEUTICS, 2009, 31 (04) : 764 - 776
  • [36] An Open-Label, Randomized, Two-Period Crossover Study of the NuvaRing Applicator in Healthy Women
    Feldman, Robert
    Frenkl, Tara
    Yacik, Carol
    Wang, Yinna
    Fox, Michelle
    OBSTETRICS AND GYNECOLOGY, 2016, 127 : 116S - 116S
  • [37] Effect of food on the pharmacokinetics of lurasidone: results of two randomized, open-label, crossover studies
    Preskorn, Sheldon
    Ereshefsky, Larry
    Chiu, Yu-Yuan
    Poola, Nagaraju
    Loebel, Antony
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (05) : 495 - 505
  • [38] Pharmacokinetic Interactions Between Bazedoxifene and Cholecalciferol: An Open-Label, Randomized, Crossover Study in Healthy Male Volunteers
    Lee, Moon Hee
    Yoon, Seok-Kyu
    Kim, Hyungsub
    Cho, Yong-Soon
    Han, Sungpil
    Lee, Shi Hyang
    Bae, Kyun-Seop
    Jung, Jina
    Hong, Sung Hee
    Lim, Hyeong-Seok
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 1107 - 1114
  • [39] Pharmacokinetics, bioavailability, and bioequivalence of lower-sodium oxybate in healthy participants in two open-label, randomized, crossover studies
    Chen, Cuiping
    Jenkins, Jack
    Zomorodi, Katie
    Skowronski, Roman
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (06): : 2278 - 2287
  • [40] Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI853520
    Verheijen, Remy B.
    van der Biessen, Diane A. J.
    Hotte, Sebastien J.
    Siu, Lillian L.
    Spreafico, Anna
    de Jonge, Maja J. A.
    Pronk, Linda C.
    De Vos, Filip Y. F. L.
    Schnell, David
    Hirte, Hal W.
    Steeghs, Neeltje
    Lolkema, Martijn P.
    TARGETED ONCOLOGY, 2019, 14 (01) : 67 - 74
12345